{"id":"dkf-ma102","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DKF-MA102 works by binding to the molecular target, which results in the desired therapeutic effect.","oneSentence":"DKF-MA102 is a small molecule drug that targets the molecular target.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:09:36.217Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT06490328","phase":"PHASE3","title":"Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer","status":"RECRUITING","sponsor":"Dongkook Pharmaceutical Co., Ltd.","startDate":"2024-05-30","conditions":"Advanced Prostate Cancer","enrollment":154}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Leuprorelin acetate"],"phase":"phase_3","status":"active","brandName":"DKF-MA102","genericName":"DKF-MA102","companyName":"Dongkook Pharmaceutical Co., Ltd.","companyId":"dongkook-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DKF-MA102 is a small molecule drug that targets the molecular target. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}